Wholesaler Discounting Dispute In Germany May Drive Novo Nordisk To Court
This article was originally published in The Pink Sheet Daily
Executive Summary
After the firm revised its early payment discounts, Novo contends that wholesalers have retaliated by providing erratic deliveries of its diabetes products.
You may also be interested in...
Novo Nordisk Comes To Terms With German Wholesalers
Agreement eases diabetes drug supply shortages, but a few wholesalers hold out for better terms.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.